Importo totale (1 articolo articoli):
Destinazione ordine:
kane gill (32 risultati)
Vai alla pagina principale dei risultati di ricerca
Filtri di ricerca
Tipo di articolo
- Tutti i tipi di prodotto
- Libri (31)
- Riviste e Giornali (Nessun altro risultato corrispondente a questo perfezionamento)
- Fumetti (1)
- Spartiti (Nessun altro risultato corrispondente a questo perfezionamento)
- Arte, Stampe e Poster (Nessun altro risultato corrispondente a questo perfezionamento)
- Fotografie (Nessun altro risultato corrispondente a questo perfezionamento)
- Mappe (Nessun altro risultato corrispondente a questo perfezionamento)
- Manoscritti e Collezionismo cartaceo (Nessun altro risultato corrispondente a questo perfezionamento)
Condizioni Maggiori informazioni
- Nuovo (24)
- Come nuovo, Ottimo o Quasi ottimo (6)
- Molto buono o Buono (1)
- Discreto o Mediocre (Nessun altro risultato corrispondente a questo perfezionamento)
- Come descritto (1)
Legatura
Ulteriori caratteristiche
- Prima ed. (2)
- Copia autograf. (1)
- Sovracoperta (Nessun altro risultato corrispondente a questo perfezionamento)
- Con foto (15)
- Non Print on Demand (19)
Lingua (1)
Spedizione gratuita
- Spedizione gratuita in U.S.A. (Nessun altro risultato corrispondente a questo perfezionamento)
Paese del venditore
Valutazione venditore
-
Showcase Presents: Robin the Boy Wonder, Vol. 1
Da: Kimmies Collection, Maryville, TN, U.S.A.
Valutazione del venditore 5 su 5 stelle
paperback. Condizione: Good. a good solid copy. clean and tight pages. fast and secure shipping.
-
Showcase Presents: Robin the Boy Wonder, Vol. 1
Da: Stock & Trade LLC, Portland, OR, U.S.A.
Valutazione del venditore 4 su 5 stelle
Prima edizione
Paperback. Condizione: Like New. First Edition. A nice paperback graphic novel, clean with a tight binding with and an unmarked text.From a private smoke free collection.Shipping within 24 hours, with a tracking number and delivery confirmation.
-
High- Risk IV Medications in Special Patient Populations.
Da: Universitätsbuchhandlung Herta Hold GmbH, Berlin, Germania
Membro dell'associazione: GIAQ ILAB VDA
Valutazione del venditore 4 su 5 stelle
EUR 12,00
Spedizione EUR 30,00
Spedito da Germania a U.S.A.Quantità: 1 disponibili
Aggiungi al carrelloXVI, 260p. Hardcover. Versand aus Deutschland / We dispatch from Germany via Air Mail. Einband bestoßen, daher Mängelexemplar gestempelt, sonst sehr guter Zustand. Imperfect copy due to slightly bumped cover, apart from this in very good condition. Stamped. Stamped. Sprache: Englisch.
-
High-Risk IV Medications in Special Patient Populations
Da: GreatBookPrices, Columbia, MD, U.S.A.
Valutazione del venditore 5 su 5 stelle
Condizione: New.
-
High-Risk IV Medications in Special Patient Populations
Da: GreatBookPricesUK, Woodford Green, Regno Unito
Valutazione del venditore 5 su 5 stelle
EUR 121,00
Spedizione EUR 17,20
Spedito da Regno Unito a U.S.A.Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
-
EUR 29,90
Spedizione EUR 105,00
Spedito da Germania a U.S.A.Quantità: 1 disponibili
Aggiungi al carrelloCondizione: Sehr gut. Zustand: Sehr gut | Seiten: 276 | Sprache: Englisch | Produktart: Bücher | Critical Care Clinicians can use general drug references (Micomedex, Lexicomp) for data on dosing of high-alert medications in special patient populations but these references are not available to all healthcare clinicians, they are expensive and they are not specific to high-alert medications or critically ill patients. Doctors, nurses and pharmacists in the hospital setting will benefit from having one resource with all of this information. The purpose of this reference manual would be to guide critical care clinicians on dosing of high-alert medications in special patient populations. The most important feature of the book will be a summary of primary literature using tables when possible. This will be useful to readers because currently a reference book does not exist that guides clinicians in these difficult dosing decisions.
-
GREEN LANTERN No. 85 Facsimile Edition (Nov. 2019) Verified Signature: NEAL ADAMS - CBCS (like CGC) Graded 9.8 (NM/MINT)
Lingua: Inglese
Editore: DC COMICS, New York, 2019
Da: OUTSIDER ENTERPRISES, Brockville, ON, Canada
Valutazione del venditore 5 su 5 stelle
Fumetto Prima edizione Copia autografata
EUR 123,43
Spedizione EUR 19,79
Spedito da Canada a U.S.A.Quantità: 1 disponibili
Aggiungi al carrelloComic. Condizione: New. ADAMS, NEAL : KANE, GILL (illustratore). 1st Edition. Comic - 1st. Print Facsimile Edition - Neal Adams Verified Signature - - CBCS Graded 9.8 (NM/MINT) White Pages - In this award-winning tale from 1971, Green Arrow discovers that his former sidekick, Roy Harper, is hooked on heroin! Plus, Sinestro tries to exert mental control over Hal Jordan in a story originally published in Green Lantern No. 11. Signed by Illustrator(s).
-
High-Risk IV Medications in Special Patient Populations
Da: Books Puddle, New York, NY, U.S.A.
Valutazione del venditore 4 su 5 stelle
Condizione: New. pp. 278.
-
High-Risk IV Medications in Special Patient Populations
Da: Ria Christie Collections, Uxbridge, Regno Unito
Valutazione del venditore 5 su 5 stelle
EUR 137,52
Spedizione EUR 13,73
Spedito da Regno Unito a U.S.A.Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
-
High-Risk IV Medications in Special Patient Populations
Da: Ria Christie Collections, Uxbridge, Regno Unito
Valutazione del venditore 5 su 5 stelle
EUR 137,52
Spedizione EUR 13,73
Spedito da Regno Unito a U.S.A.Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
-
High-Risk IV Medications in Special Patient Populations
Da: Books Puddle, New York, NY, U.S.A.
Valutazione del venditore 4 su 5 stelle
Condizione: New. pp. 278.
-
High-risk IV Medications in Special Patient Populations
Da: Revaluation Books, Exeter, Regno Unito
Valutazione del venditore 5 su 5 stelle
EUR 149,49
Spedizione EUR 14,33
Spedito da Regno Unito a U.S.A.Quantità: 2 disponibili
Aggiungi al carrelloHardcover. Condizione: Brand New. 1st edition. 260 pages. 9.75x6.50x0.75 inches. In Stock.
-
High-Risk IV Medications in Special Patient Populations
Da: GreatBookPricesUK, Woodford Green, Regno Unito
Valutazione del venditore 5 su 5 stelle
EUR 159,39
Spedizione EUR 17,20
Spedito da Regno Unito a U.S.A.Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
-
High-Risk IV Medications in Special Patient Populations
Lingua: Inglese
Editore: Springer London, Springer London, 2011
ISBN 10: 0857296051 ISBN 13: 9780857296054
EUR 111,53
Spedizione EUR 62,91
Spedito da Germania a U.S.A.Quantità: 1 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - Critically ill patients are at risk for a higher frequency and severity of adverse drug events (ADEs), and special patient populations of the critically ill requiring for instance individualized dosing due to non-average weight, hepatic or renal dysfunction, extracorporeal circulation devices, advanced age, pharmacogenetic alterations, hemodynamic instability, or therapeutic hypothermia are particularly challenging. A contributing factor to this is the use of high-risk medications with many administered intravenously (IV). Hypervigilant monitoring of high-risk medications is still essential to prevent patient harm, especially in populations that have dosing challenges, hence, regulatory bodies internationally require active institutional surveillance of high-risk medications. These dosing challenges are a great safety concern, since there is considerable risk of unwanted adverse drug events from overdosing or therapeutic inefficacy from underdosing.High-Risk IV Medications in Special Patient Populations reviews high-risk IV medication dosage considerations for special patient populations and discusses the safety concerns of these medications to aid the clinician in cautious monitoring. The authors provide clinicians with tools to minimize adverse drug events with IV high-risk medications, while maximizing the beneficial clinical effects of these drugs, thus making this book essential reading for all involved with the care of critically ill patients.
-
High-Risk IV Medications in Special Patient Populations
Da: Mispah books, Redhill, SURRE, Regno Unito
Valutazione del venditore 4 su 5 stelle
EUR 149,95
Spedizione EUR 28,66
Spedito da Regno Unito a U.S.A.Quantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: Like New. Like New. book.
-
High-Risk IV Medications in Special Patient Populations
Da: GreatBookPrices, Columbia, MD, U.S.A.
Valutazione del venditore 5 su 5 stelle
Condizione: As New. Unread book in perfect condition.
-
EUR 113,10
Spedizione EUR 70,00
Spedito da Germania a U.S.A.Quantità: 5 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. High-Risk IV Medications in Special Patient Populations | Sandra Kane-Gill (u. a.) | Taschenbuch | x | Englisch | 2014 | Springer | EAN 9781447158684 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
-
High-Risk IV Medications in Special Patient Populations
Lingua: Inglese
Editore: Springer London, Springer London, 2014
ISBN 10: 1447158687 ISBN 13: 9781447158684
EUR 131,13
Spedizione EUR 62,12
Spedito da Germania a U.S.A.Quantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - Critical Care Clinicians can use general drug references (Micomedex, Lexicomp) for data on dosing of high-alert medications in special patient populations but these references are not available to all healthcare clinicians, they are expensive and they are not specific to high-alert medications or critically ill patients. Doctors, nurses and pharmacists in the hospital setting will benefit from having one resource with all of this information. The purpose of this reference manual would be to guide critical care clinicians on dosing of high-alert medications in special patient populations. The most important feature of the book will be a summary of primary literature using tables when possible. This will be useful to readers because currently a reference book does not exist that guides clinicians in these difficult dosing decisions.
-
High-Risk IV Medications in Special Patient Populations
Da: Mispah books, Redhill, SURRE, Regno Unito
Valutazione del venditore 4 su 5 stelle
EUR 203,09
Spedizione EUR 28,66
Spedito da Regno Unito a U.S.A.Quantità: 1 disponibili
Aggiungi al carrelloPaperback. Condizione: Like New. Like New. book.
-
High-Risk IV Medications in Special Pat (eng)
Da: Brook Bookstore On Demand, Napoli, NA, Italia
Valutazione del venditore 4 su 5 stelle
EUR 86,24
Spedizione EUR 6,80
Spedito da Italia a U.S.A.Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: new. Questo è un articolo print on demand.
-
High-Risk IV Medications in Special Pat (eng)
Da: Brook Bookstore On Demand, Napoli, NA, Italia
Valutazione del venditore 4 su 5 stelle
EUR 102,25
Spedizione EUR 5,50
Spedito da Italia a U.S.A.Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: new. Questo è un articolo print on demand.
-
High-Risk IV Medications in Special Patient Populations
Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germania
Valutazione del venditore 5 su 5 stelle
EUR 106,99
Spedizione EUR 23,00
Spedito da Germania a U.S.A.Quantità: 2 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Critically ill patients are at risk for a higher frequency and severity of adverse drug events (ADEs), and special patient populations of the critically ill requiring for instance individualized dosing due to non-average weight, hepatic or renal dysfunction, extracorporeal circulation devices, advanced age, pharmacogenetic alterations, hemodynamic instability, or therapeutic hypothermia are particularly challenging. A contributing factor to this is the use of high-risk medications with many administered intravenously (IV). Hypervigilant monitoring of high-risk medications is still essential to prevent patient harm, especially in populations that have dosing challenges, hence, regulatory bodies internationally require active institutional surveillance of high-risk medications. These dosing challenges are a great safety concern, since there is considerable risk of unwanted adverse drug events from overdosing or therapeutic inefficacy from underdosing.High-Risk IV Medications in Special Patient Populations reviews high-risk IV medication dosage considerations for special patient populations and discusses the safety concerns of these medications to aid the clinician in cautious monitoring. The authors provide clinicians with tools to minimize adverse drug events with IV high-risk medications, while maximizing the beneficial clinical effects of these drugs, thus making this book essential reading for all involved with the care of critically ill patients. 276 pp. Englisch.
-
EUR 89,99
Spedizione EUR 48,99
Spedito da Germania a U.S.A.Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. The Institute for Safe Medication Practices has developed a list of high-alert medications which are medications at a heightened risk for patient harm when used in errorNo book has been published on this topic A resource containing all rele.
-
High-Risk IV Medications in Special Patient Populations
Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germania
Valutazione del venditore 5 su 5 stelle
EUR 128,39
Spedizione EUR 23,00
Spedito da Germania a U.S.A.Quantità: 2 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Critical Care Clinicians can use general drug references (Micomedex, Lexicomp) for data on dosing of high-alert medications in special patient populations but these references are not available to all healthcare clinicians, they are expensive and they are not specific to high-alert medications or critically ill patients. Doctors, nurses and pharmacists in the hospital setting will benefit from having one resource with all of this information. The purpose of this reference manual would be to guide critical care clinicians on dosing of high-alert medications in special patient populations. The most important feature of the book will be a summary of primary literature using tables when possible. This will be useful to readers because currently a reference book does not exist that guides clinicians in these difficult dosing decisions. 276 pp. Englisch.
-
High-Risk IV Medications in Special Patient Populations
Da: Majestic Books, Hounslow, Regno Unito
Valutazione del venditore 4 su 5 stelle
EUR 153,03
Spedizione EUR 7,45
Spedito da Regno Unito a U.S.A.Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New. Print on Demand pp. 278 3 Illus. (2 Col.).
-
EUR 107,09
Spedizione EUR 48,99
Spedito da Germania a U.S.A.Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. The Institute for Safe Medication Practices has developed a list of high-alert medications which are medications at a heightened risk for patient harm when used in errorNo book has been published on this topic A resource containing all rele.
-
High-Risk IV Medications in Special Patient Populations
Da: Majestic Books, Hounslow, Regno Unito
Valutazione del venditore 4 su 5 stelle
EUR 158,80
Spedizione EUR 7,45
Spedito da Regno Unito a U.S.A.Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New. Print on Demand pp. 278.
-
EUR 93,35
Spedizione EUR 70,00
Spedito da Germania a U.S.A.Quantità: 5 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. High-Risk IV Medications in Special Patient Populations | Sandra Kane-Gill (u. a.) | Buch | x | Englisch | 2011 | Springer | EAN 9780857296054 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu Print on Demand.
-
High-Risk IV Medications in Special Patient Populations
Da: Biblios, Frankfurt am main, HESSE, Germania
Valutazione del venditore 4 su 5 stelle
EUR 155,00
Spedizione EUR 9,95
Spedito da Germania a U.S.A.Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New. PRINT ON DEMAND pp. 278.
-
High-Risk IV Medications in Special Patient Populations
Lingua: Inglese
Editore: Springer, Springer Jun 2011, 2011
ISBN 10: 0857296051 ISBN 13: 9780857296054
Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germania
Valutazione del venditore 5 su 5 stelle
EUR 106,99
Spedizione EUR 60,00
Spedito da Germania a U.S.A.Quantità: 1 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Critical Care Clinicians can use general drug references (Micomedex, Lexicomp) for data on dosing of high-alert medications in special patient populations but these references are not available to all healthcare clinicians, they are expensive and they are not specific to high-alert medications or critically ill patients. Doctors, nurses and pharmacists in the hospital setting will benefit from having one resource with all of this information. The purpose of this reference manual would be to guide critical care clinicians on dosing of high-alert medications in special patient populations. The most important feature of the book will be a summary of primary literature using tables when possible. This will be useful to readers because currently a reference book does not exist that guides clinicians in these difficult dosing decisions.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 276 pp. Englisch.
